XML 25 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Deferred Stock Units
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interest
Balance beginning of period (in shares) at Dec. 31, 2020   106,457            
Balance beginning of period at Dec. 31, 2020 $ 632,795 $ 10,646 $ 1,294,849 $ 4,503 $ 2,175,595 $ (53,615) $ (2,799,890) $ 707
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 744,844       744,845     (1)
Other comprehensive gain (loss), net 131         131    
Acquisition of noncontrolling interest (Note 4) (990)   (284)         (706)
Repurchases of common stock, net (770,801)           (770,801)  
Common stock issued under stock plans, net (in shares)   421            
Common stock issued under stock plans, net 46,258 $ 42 46,228 (12)        
Deferred stock units activity 0   (1,035) 1,035        
Share-based compensation cost 37,755   37,562 193        
Balance end of period (in shares) at Dec. 31, 2021   106,878            
Balance end of period at Dec. 31, 2021 689,992 $ 10,688 1,377,320 5,719 2,920,440 (53,484) (3,570,691) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 679,089       679,089      
Other comprehensive gain (loss), net (24,312)         (24,312)    
Acquisition of noncontrolling interest (Note 4) 0              
Repurchases of common stock, net (821,421)           (821,421)  
Common stock issued under stock plans, net (in shares)   315            
Common stock issued under stock plans, net 35,619 $ 31 36,654 (1,066)        
Deferred stock units activity 0   (459) 459        
Share-based compensation cost $ 49,770   49,700 70        
Balance end of period (in shares) at Dec. 31, 2022 107,193 107,193            
Balance end of period at Dec. 31, 2022 $ 608,737 $ 10,719 1,463,215 5,182 3,599,529 (77,796) (4,392,112) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 845,042       845,042      
Other comprehensive gain (loss), net 6,590         6,590    
Repurchases of common stock, net (82,569)           (82,569)  
Common stock issued under stock plans, net (in shares)   313            
Common stock issued under stock plans, net 46,991 $ 32 46,984 (25)        
Deferred stock units activity 0   (345) 345        
Share-based compensation cost $ 59,739   59,711 28        
Balance end of period (in shares) at Dec. 31, 2023 107,506 107,506            
Balance end of period at Dec. 31, 2023 $ 1,484,530 $ 10,751 $ 1,569,565 $ 5,530 $ 4,444,571 $ (71,206) $ (4,474,681) $ 0